Meeting News

Kahook, Samuelson debate MIGS procedures with phaco

January 24, 2020
KOLOA, Hawaii — Excisional goniotomy is just as safe and effective as device procedures for the treatment of mild-to-moderate glaucoma, Malik

Meeting NewsVideo

VIDEO: Goniotomy a good IOP-lowering option in different situations

January 23, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Jella An, MD, discusses how she has incorporated the Kahook Dual Blade (New World Medical) goniotomy…

Meeting News

Ocular surface disease an important consideration in glaucoma

January 22, 2020
KOLOA, Hawaii — The ocular surface should not be forgotten when managing patients with glaucoma, according to a presenter at Hawaiian Eye 2020…

Meeting NewsVideo

VIDEO: ‘Absolute blitz’ in glaucoma innovation underway

January 22, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Savak “Sev” Teymoorian, MD, MBA, discusses the crowded field of glaucoma treatment…

Meeting News

Radcliffe: What not to miss on a glaucoma exam

January 22, 2020
KOLOA, Hawaii — The initial patient visit is an important step in glaucoma management, Nathan M. Radcliffe, MD, told colleagues at Hawaiian…

Meeting NewsVideo

VIDEO: Laser remains useful in lowering IOP in glaucoma

January 21, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Janet B. Serle, MD, discusses the three types of laser used in glaucoma treatment.

Aerie’s Ireland facility for Rocklatan production approved

January 21, 2020
The FDA has approved a facility in Athlone, Ireland, for production of Rocklatan for the U.S. market, Aerie Pharmaceuticals announced in a press…

Vyzulta approved in Hong Kong, Argentina

January 20, 2020
Regulatory bodies in Hong Kong and Argentina have approved Vyzulta for the reduction of IOP in patients with open-angle glaucoma or ocular…

Meeting News

Santen plans entry in US glaucoma market

January 14, 2020
Santen plans to break into the U.S. glaucoma market in 2020 with the introduction of the DE-128 microshunt, according to a speaker at the 38th annual…

Vyzulta approved in Mexico

January 13, 2020
Vyzulta has been approved in Mexico for the reduction of IOP in patients with open-angle glaucoma or ocular hypertension, Nicox announced in a press…

ICYMI: Last week’s leading headlines

January 12, 2020
Keep up to date with the big news in ophthalmology. Here are some important stories you might have missed on Healio.com/OSN from the past week:

Aerpio’s AKB-9778 as adjunct reduces IOP in phase 1b trial

January 9, 2020
A topical ocular formulation of AKB-9778 given as an adjunctive therapy reduced IOP and was well tolerated in patients with ocular hypertension or…

Meeting NewsVideo

VIDEO: Combining MIGS for best outcomes

January 9, 2020
NEW YORK — Nathan M. Radcliffe, MD, discusses combining MIGS and medication and the possibility of combining MIGS procedures in the future…

Point/Counter

What is your treatment process when a lifesaving therapy results in worsening ocular symptoms?

Ocular Surgery News U.S. Edition, January 25, 2020
As a retina specialist, my busy private practice sees a wide spectrum of the patient population. We have a significant number of patients on…

Cover Story

Systemic drugs and their ocular symptoms can complicate treatment

Ocular Surgery News U.S. Edition, January 25, 2020
Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, the treatment paradigms can be…

Microshunt moves aqueous to ocular surface

Ocular Surgery News U.S. Edition, January 25, 2020
A new glaucoma microshunt that drains the aqueous onto the ocular surface is advancing its way through studies. “It is the first and only…

Lindstrom's Perspective

Close monitoring needed to avoid drug-induced ocular side effects

Ocular Surgery News U.S. Edition, January 25, 2020
Richard L. Lindstrom, MD
Drug-induced ocular side effects are common in every ophthalmologist’s practice. When we review our senior patients’ lists of medicines…

Meeting NewsVideo

VIDEO: Stents, trabs and tubes: Which procedure and when?

January 8, 2020
NEW YORK — During his presentation at OSN New York 2019, Thomas W. Samuelson, MD, discusses surgical treatment options for glaucoma and when…

Meeting NewsVideo

VIDEO: Should SLT be the preferred first-line treatment?

January 7, 2020
NEW YORK — In her presentation at OSN New York 2019, Valerie Trubnik, MD, FACS, discusses results of the LiGHT trial, which compared selective…

Meeting NewsVideo

VIDEO: New drugs will change glaucoma management

January 7, 2020
NEW YORK — During his presentation at OSN New York 2019, Robert J. Noecker, MD, MBA, discusses pharmacological treatment options for glaucoma…